Literature DB >> 22158876

Foot-and-mouth disease virus epitope dominance in the antibody response of vaccinated animals.

M Mahapatra1, P Hamblin1, D J Paton1.   

Abstract

Five neutralizing antigenic sites have been identified on the surface of serotype O foot-and-mouth disease virus (FMDV). A set of mAb neutralization-escape mutant viruses was used for the first time to evaluate the relative use of known binding sites by polyclonal antibodies from three target species: cattle, sheep and pigs. Antibodies to all five neutralizing antigenic sites were detected in all three species, with most antibodies directed against antigenic site 2, followed by antigenic site 1. In 76 % of cattle, 65 % of sheep and 58 % of pigs, most antibodies were directed against site 2. Antibodies specific to antigenic sites 3, 4 and 5 were found to be minor constituents in the sera of each of the target species. This implies that antigenic site 2 is a dominant neutralization immunogenic site in serotype O FMDV and may therefore be a good candidate for designing novel vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22158876     DOI: 10.1099/vir.0.037952-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Single amino acid substitution of VP1 N17D or VP2 H145Y confers acid-resistant phenotype of type Asia1 foot-and-mouth disease virus.

Authors:  Haiwei Wang; Shanshan Song; Jianxiong Zeng; Guohui Zhou; Decheng Yang; Te Liang; Li Yu
Journal:  Virol Sin       Date:  2014-03-26       Impact factor: 4.327

2.  Phage Display Screening of Bovine Antibodies to Foot-and-Mouth Disease Virus and Their Application in a Competitive ELISA for Serodiagnosis.

Authors:  Sukyo Jeong; Hyun Joo Ahn; Kyung Jin Min; Jae Won Byun; Hyun Mi Pyo; Mi Young Park; Bok Kyung Ku; Jinju Nah; Soyoon Ryoo; Sung Hwan Wee; Sang Jick Kim
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

3.  Genetic Diversity of Circulating Foot and Mouth Disease Virus in Uganda Cross-Sectional Study During 2014-2017.

Authors:  Lauro Velazquez-Salinas; Frank Norbert Mwiine; Zaheer Ahmed; Sylvester Ochwo; Anna Munsey; Julius J Lutwama; Andres M Perez; Kimberly VanderWaal; Elizabeth Rieder
Journal:  Front Vet Sci       Date:  2020-03-25

4.  Determining the epitope dominance on the capsid of a serotype SAT2 foot-and-mouth disease virus by mutational analyses.

Authors:  Pamela A Opperman; Lia S Rotherham; Jan Esterhuysen; Bryan Charleston; Nicholas Juleff; Alejandra V Capozzo; Jacques Theron; Francois F Maree
Journal:  J Virol       Date:  2014-05-14       Impact factor: 5.103

5.  Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses.

Authors:  Mana Mahapatra; S Yuvaraj; M Madhanmohan; S Subramaniam; B Pattnaik; D J Paton; V A Srinivasan; Satya Parida
Journal:  Vaccine       Date:  2014-12-10       Impact factor: 3.641

6.  Novel antibody binding determinants on the capsid surface of serotype O foot-and-mouth disease virus.

Authors:  Amin S Asfor; Sasmita Upadhyaya; Nick J Knowles; Donald P King; David J Paton; Mana Mahapatra
Journal:  J Gen Virol       Date:  2014-02-28       Impact factor: 3.891

7.  Genetic basis of antigenic variation in foot-and-mouth disease serotype A viruses from the Middle East.

Authors:  Sasmita Upadhyaya; Gelagay Ayelet; Guntram Paul; Donald P King; David J Paton; Mana Mahapatra
Journal:  Vaccine       Date:  2013-09-10       Impact factor: 3.641

8.  Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.

Authors:  Ming Yang; Wanhong Xu; Melissa Goolia; Zhidong Zhang
Journal:  Virol J       Date:  2014-08-01       Impact factor: 4.099

9.  Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions.

Authors:  Mana Mahapatra; Bob Statham; Yanmin Li; Jef Hammond; David Paton; Satya Parida
Journal:  Vaccine       Date:  2016-03-24       Impact factor: 3.641

10.  Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain.

Authors:  Katie Lloyd-Jones; Mana Mahapatra; Sasmita Upadhyaya; David J Paton; Aravindh Babu; Geoff Hutchings; Satya Parida
Journal:  Vaccine       Date:  2017-12-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.